Flamel Technologies SA (NASDAQ:FLML) dropped 5.1% during mid-day trading on Wednesday . The company traded as low as $12.86 and last traded at $12.90, with a volume of 97,515 shares. The stock had previously closed at $13.59.

A number of equities research analysts recently weighed in on the company. Leerink Swann restated a “buy” rating and issued a $16.00 price target on shares of Flamel Technologies SA in a research note on Tuesday, May 10th. Zacks Investment Research cut Flamel Technologies SA from a “hold” rating to a “sell” rating in a research note on Tuesday, May 10th. Two equities research analysts have rated the stock with a hold rating and five have assigned a buy rating to the company. The company has a consensus rating of “Buy” and a consensus price target of $18.63.

The stock has a market cap of $529.12 million and a PE ratio of 31.07. The company’s 50-day moving average price is $11.74 and its 200 day moving average price is $10.64.

Flamel Technologies SA (NASDAQ:FLML) last announced its quarterly earnings data on Monday, August 8th. The company reported ($0.02) EPS for the quarter, missing the Zacks’ consensus estimate of $0.06 by $0.08. The business earned $38.90 million during the quarter, compared to analysts’ expectations of $32.80 million. During the same period in the previous year, the business earned $0.34 earnings per share. The business’s revenue for the quarter was down 20.0% on a year-over-year basis. On average, equities research analysts predict that Flamel Technologies SA will post ($0.03) earnings per share for the current year.

In related news, CEO Michael S. Anderson bought 5,000 shares of the business’s stock in a transaction that occurred on Thursday, May 12th. The shares were bought at an average price of $8.84 per share, with a total value of $44,200.00. Following the completion of the transaction, the chief executive officer now directly owns 134,250 shares in the company, valued at $1,186,770. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Craig R. Stapleton bought 27,228 shares of the business’s stock in a transaction that occurred on Monday, May 16th. The shares were bought at an average cost of $9.21 per share, for a total transaction of $250,769.88. Following the transaction, the director now owns 507,263 shares of the company’s stock, valued at $4,671,892.23. The disclosure for this purchase can be found here.

A hedge fund recently raised its stake in Flamel Technologies SA stock. Morgan Stanley increased its stake in shares of Flamel Technologies SA (NASDAQ:FLML) by 131.4% during the fourth quarter, according to its most recent 13F filing with the SEC. The firm owned 719,463 shares of the company’s stock after buying an additional 408,531 shares during the period. Morgan Stanley owned about 1.78% of Flamel Technologies SA worth $8,785,000 as of its most recent SEC filing.

Flamel Technologies SA is a specialty pharmaceutical company. The Company is engaged in the development and commercialization of pharmaceutical products, including controlled-release therapeutic products based on its polymer based technology. The Company has a balanced business model consisting of an Unapproved Marketed Drugs (UMDs) business with over two approved products in the United States, Bloxiverz (neostigmine methylsulfate injection) and Vazculep (phenylephrine hydrochloride injection) that are marketed; a branded pediatric business, and a branded business, focusing on the development of products utilizing Flamel’s drug delivery platforms.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.